News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
40,168 Results
Type
Article (2580)
Company Profile (45)
Press Release (37542)
Multimedia
Podcasts (9)
Webinars (2)
Section
Business (14209)
Career Advice (79)
Deals (2111)
Drug Delivery (9)
Drug Development (4156)
Employer Resources (10)
FDA (443)
Job Trends (785)
News (20303)
Policy (1059)
Tag
Academia (144)
Allergies (7)
Alliances (3493)
ALS (6)
Alzheimer's disease (59)
Antibody-drug conjugate (ADC) (27)
Approvals (446)
Artificial intelligence (31)
Autoimmune disease (8)
Automation (2)
Bankruptcy (12)
Best Places to Work (477)
BIOSECURE Act (2)
Biosimilars (16)
Biotechnology (29)
Bladder cancer (8)
Brain cancer (7)
Breast cancer (45)
Cancer (325)
Cardiovascular disease (10)
Career advice (67)
Career pathing (1)
CAR-T (31)
CDC (1)
Cell therapy (81)
Cervical cancer (2)
Clinical research (3450)
Collaboration (199)
Company closure (2)
Compensation (104)
COVID-19 (185)
CRISPR (11)
C-suite (112)
Cystic fibrosis (7)
Data (419)
Denatured (6)
Depression (11)
Diabetes (17)
Diagnostics (488)
Digital health (2)
Diversity (2)
Diversity, equity & inclusion (1)
Drug discovery (36)
Drug pricing (10)
Duchenne muscular dystrophy (40)
Earnings (4512)
Editorial (5)
Employer branding (1)
Employer resources (8)
Events (6406)
Executive appointments (134)
FDA (588)
Friedreich's ataxia (4)
Frontotemporal dementia (1)
Funding (169)
Gene editing (32)
Generative AI (1)
Gene therapy (55)
GLP-1 (63)
Government (158)
Guidances (24)
Healthcare (708)
HIV (1)
Huntington's disease (5)
IgA nephropathy (12)
Immunology and inflammation (34)
Immuno-oncology (14)
Indications (4)
Infectious disease (197)
Inflammatory bowel disease (15)
Inflation Reduction Act (6)
Influenza (7)
Intellectual property (25)
Interviews (7)
IPO (1007)
IRA (7)
Job creations (295)
Job search strategy (62)
JPM (4)
Kidney cancer (6)
Labor market (11)
Layoffs (51)
Leadership (3)
Legal (216)
Liver cancer (6)
Longevity (1)
Lung cancer (28)
Lymphoma (12)
Machine learning (3)
Management (4)
Manufacturing (52)
MASH (14)
Medical device (314)
Medtech (315)
Mergers & acquisitions (1220)
Metabolic disorders (72)
Multiple sclerosis (22)
Neurodegenerative disease (27)
Neuropsychiatric disorders (10)
Neuroscience (165)
NextGen: Class of 2026 (353)
Non-profit (157)
Now hiring (11)
Obesity (32)
Opinion (17)
Ovarian cancer (17)
Pain (24)
Pancreatic cancer (21)
Parkinson's disease (11)
Partnered (4)
Patents (53)
Patient recruitment (25)
Peanut (1)
People (5880)
Pharmaceutical (5)
Phase 1 (1474)
Phase 2 (1710)
Phase 3 (922)
Pipeline (394)
Policy (16)
Postmarket research (30)
Preclinical (640)
Press Release (2)
Prostate cancer (7)
Psychedelics (3)
Radiopharmaceuticals (14)
Rare diseases (62)
Real estate (425)
Recruiting (5)
Regulatory (917)
Reports (7)
Research institute (149)
Resumes & cover letters (10)
Rett syndrome (1)
RNA editing (5)
RSV (1)
Schizophrenia (17)
Series A (47)
Series B (21)
Service/supplier (2)
Sickle cell disease (3)
Special edition (3)
Spinal muscular atrophy (2)
Sponsored (1)
Startups (498)
Stomach cancer (2)
Supply chain (4)
Tariffs (2)
The Weekly (3)
Vaccines (52)
Venture capital (15)
Weight loss (21)
Women's health (10)
Worklife (1)
Date
Last 7 days (40)
Last 30 days (155)
Last 365 days (2420)
2026 (213)
2025 (2446)
2024 (2612)
2023 (2859)
2022 (3752)
2021 (4053)
2020 (3475)
2019 (2071)
2018 (1559)
2017 (1799)
2016 (1632)
2015 (1846)
2014 (1375)
2013 (1192)
2012 (1397)
2011 (1333)
2010 (1181)
Location
Africa (44)
Alabama (3)
Arizona (18)
Asia (1948)
Australia (308)
California (1604)
Canada (241)
China (80)
Colorado (54)
Connecticut (16)
Delaware (5)
Europe (4017)
Florida (66)
Georgia (12)
Hawaii (2)
Idaho (3)
Illinois (21)
India (2)
Indiana (60)
Japan (17)
Kansas (14)
Kentucky (1)
Maryland (49)
Massachusetts (570)
Michigan (14)
Minnesota (22)
Mississippi (1)
Missouri (4)
Nebraska (1)
Nevada (3)
New Hampshire (4)
New Jersey (133)
New York (82)
North Carolina (131)
Northern California (782)
Ohio (44)
Oklahoma (2)
Oregon (6)
Pennsylvania (109)
Puerto Rico (1)
Rhode Island (2)
South America (40)
South Carolina (1)
Southern California (653)
Tennessee (4)
Texas (152)
United States (3214)
Utah (5)
Virginia (11)
Washington D.C. (3)
Washington State (97)
West Virginia (1)
Wisconsin (13)
40,168 Results for "spruce biosciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Spruce Biosciences Adds Regulatory and Clinical Development Expertise to Leadership Team
February 4, 2026
·
5 min read
Press Releases
Spruce Biosciences Announces Data Presentations at the 22nd Annual WORLDSymposium™
January 29, 2026
·
2 min read
Press Releases
Harbour BioMed Acquires Common Stock in Spruce Biosciences, Deepening Strategic Collaboration
January 19, 2026
·
2 min read
Press Releases
Spruce Biosciences Secures Up to $50 Million in Growth Capital from Avenue Capital
January 8, 2026
·
5 min read
Press Releases
Spruce Biosciences Appoints Proven Pharmaceutical Commercial Leader Keli Walbert to Board of Directors
December 16, 2025
·
4 min read
Press Releases
Spruce Biosciences Reports Third Quarter 2025 Financial Results and Provides Corporate Updates
November 10, 2025
·
8 min read
Press Releases
Spruce Biosciences Resumes Trading on the Nasdaq Capital Market
September 15, 2025
·
1 min read
Press Releases
Spruce Biosciences Announces $50.0 Million Private Placement Financing
October 9, 2025
·
4 min read
Layoffs
Spruce Axes 55% of Staff, Leaving Shoestring Crew To Focus on New Rare Disease Asset
Spruce Biosciences is cutting over half of its employees as it looks to secure accelerated approval of a Sanfilippo syndrome therapy it recently acquired from BioMarin.
April 28, 2025
·
1 min read
·
Angela Gabriel
Press Releases
Spruce Biosciences Reports Second Quarter 2025 Financial Results and Provides Corporate Updates
August 15, 2025
·
11 min read
1 of 4,017
Next
